Metabolic syndrome and risk of cancer: which link? - PubMed (original) (raw)
Review
Metabolic syndrome and risk of cancer: which link?
Fernando Miguel Mendonça et al. Metabolism. 2015 Feb.
Abstract
Metabolic syndrome (MS) is characterized by a group of metabolic disturbances which lead to an enhanced risk of cardiovascular diseases and type 2 diabetes mellitus. MS constitutes a preoccupant issue with elevated prevalence in the western countries and is often related with cancer development. Elucidating the mechanisms linking these two pathologies is, therefore, essential to identify potential therapeutic molecular targets for cancer treatment in MS patients. The main goals of this review are, to identify the relation between MS and cancer development, handling specifically each one of the main players on this process: insulin and IGF system, estrogen, pro-inflammatory cytokines and others; and, given that colorectal cancer is one of the most prevalent types of cancer in MS patients, we intend to particularly highlight the mechanisms that promote colorectal cancer development in MS individuals. Finally, we will also focus on the clinical implications of the presented mechanisms on cancer therapy and care.
Keywords: Cancer progression; Colorectal cancer; Metabolic syndrome; Molecular mechanisms; Therapeutic targets.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
- Diabetes mellitus as a novel risk factor for gastrointestinal malignancies.
Herrigel DJ, Moss RA. Herrigel DJ, et al. Postgrad Med. 2014 Oct;126(6):106-18. doi: 10.3810/pgm.2014.10.2825. Postgrad Med. 2014. PMID: 25414939 Review. - Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
Sciacca L, Vigneri R, Tumminia A, Frasca F, Squatrito S, Frittitta L, Vigneri P. Sciacca L, et al. Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):808-15. doi: 10.1016/j.numecd.2013.05.006. Epub 2013 Aug 7. Nutr Metab Cardiovasc Dis. 2013. PMID: 23932729 Review. - Epidemiological aspects of neoplasms in diabetes.
Nicolucci A. Nicolucci A. Acta Diabetol. 2010 Jun;47(2):87-95. doi: 10.1007/s00592-010-0187-3. Epub 2010 Apr 8. Acta Diabetol. 2010. PMID: 20376506 Review. - [Diabetes and cancer: an injurious association].
Gariani K, Tran C, Philippe J. Gariani K, et al. Rev Med Suisse. 2010 Jun 9;6(252):1193-4, 1196-8. Rev Med Suisse. 2010. PMID: 20614754 French. - Diabetes and cancer: Could vitamin D provide the link?
Ahmad S, Chowdhury TA, Boucher BJ. Ahmad S, et al. J Diabetes Complications. 2013 Mar-Apr;27(2):184-90. doi: 10.1016/j.jdiacomp.2012.10.005. Epub 2012 Nov 17. J Diabetes Complications. 2013. PMID: 23164631 Review.
Cited by
- Understanding the Link between Sugar and Cancer: An Examination of the Preclinical and Clinical Evidence.
Epner M, Yang P, Wagner RW, Cohen L. Epner M, et al. Cancers (Basel). 2022 Dec 8;14(24):6042. doi: 10.3390/cancers14246042. Cancers (Basel). 2022. PMID: 36551528 Free PMC article. Review. - Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations.
Mili N, Paschou SA, Goulis DG, Dimopoulos MA, Lambrinoudaki I, Psaltopoulou T. Mili N, et al. Endocrine. 2021 Dec;74(3):478-497. doi: 10.1007/s12020-021-02884-x. Epub 2021 Oct 8. Endocrine. 2021. PMID: 34625915 Review. - Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications.
Gong M, Wen S, Nguyen T, Wang C, Jin J, Zhou L. Gong M, et al. Diabetes Metab Syndr Obes. 2020 Mar 30;13:943-962. doi: 10.2147/DMSO.S232377. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 32280253 Free PMC article. Review. - Long-term Risk of Malignant Neoplastic Disorders in Type 2 Diabetes Mellitus Patients with Metabolic Syndrome.
Albai O, Frandes M, Timar B, Paun DL, Roman D, Timar R. Albai O, et al. Diabetes Metab Syndr Obes. 2020 Apr 23;13:1317-1326. doi: 10.2147/DMSO.S243263. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 32368123 Free PMC article. - Impaired Melatonin Secretion, Oxidative Stress and Metabolic Syndrome in Night Shift Work.
Hohor S, Mandanach C, Maftei A, Zugravu CA, Oțelea MR. Hohor S, et al. Antioxidants (Basel). 2023 Apr 19;12(4):959. doi: 10.3390/antiox12040959. Antioxidants (Basel). 2023. PMID: 37107334 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical